Lalisang RI - Search Results

1

Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy.

Lalisang RI, Erdkamp FL, Rodenburg CJ, Knibbeler-van Rossum CT, Nortier JW, van Bochove A, Slee PH, Voest EE, Wils JA, Wals J, Loosveld OJ, Smals AE, Blijham GH, Tjan-Heijnen VC, Schouten HC. Lalisang RI, et al. Breast Cancer Res Treat. 2011 Jul;128(2):437-45. doi: 10.1007/s10549-011-1558-3. Epub 2011 May 17. Breast Cancer Res Treat. 2011. PMID: 21584666 Clinical Trial.

2

Comparative study of dose escalation versus interval reduction to obtain dose-intensification of epirubicin and cyclophosphamide with granulocyte colony-stimulating factor in advanced breast cancer.

Lalisang RI, Wils JA, Nortier HW, Burghouts JT, Hupperets PS, Erdkamp FL, Schouten HC, Blijham GH. Lalisang RI, et al. J Clin Oncol. 1997 Apr;15(4):1367-76. doi: 10.1200/JCO.1997.15.4.1367. J Clin Oncol. 1997. PMID: 9193328 Clinical Trial.

3

High-dose chemotherapy with autologous bone marrow support as consolidation after standard-dose adjuvant therapy in primary breast cancer patients with seven or more involved axillary lymph nodes.

Lalisang RI, Hupperets PS, ten Haaft MA, Jansen RL, Schouten HC. Lalisang RI, et al. Bone Marrow Transplant. 1998 Feb;21(3):243-7. doi: 10.1038/sj.bmt.1701071. Bone Marrow Transplant. 1998. PMID: 9489646 Clinical Trial.

4

Dose-dense epirubicin and paclitaxel with G-CSF: a study of decreasing intervals in metastatic breast cancer.

Lalisang RI, Voest EE, Wils JA, Nortier JW, Erdkamp FL, Hillen HF, Wals J, Schouten HC, Blijham GH. Lalisang RI, et al. Br J Cancer. 2000 Jun;82(12):1914-9. doi: 10.1054/bjoc.2000.1202. Br J Cancer. 2000. PMID: 10864197 Free PMC article. Clinical Trial.

5

Treatment of elderly patients with intermediate- and high-grade non-Hodgkin's lymphoma: a retrospective population-based study.

Peters FP, Lalisang RI, Fickers MM, Erdkamp FL, Wils JA, Houben SG, Wals J, Schouten HC. Peters FP, et al. Among authors: lalisang ri. Ann Hematol. 2001 Mar;80(3):155-9. doi: 10.1007/s002770000255. Ann Hematol. 2001. PMID: 11320900

6

Non-myeloablative allogeneic stem cell transplantation in patients with solid tumours and patients with a haematological malignancy.

Huugen D, Bos GM, Jansen M, Lalisang R, Jansen R, Wagstaff J, Schouten HC. Huugen D, et al. Neth J Med. 2002 May;60(4):170-3. Neth J Med. 2002. PMID: 12164395 Free article.

7

HLA-matched allo-SCT after reduced intensity conditioning with fludarabine/CY in patients with metastatic breast cancer.

Fleskens AJ, Lalisang RI, Bos GM, van Gelder M, Jansen RL, Schouten HC. Fleskens AJ, et al. Among authors: lalisang ri. Bone Marrow Transplant. 2010 Mar;45(3):464-7. doi: 10.1038/bmt.2009.178. Epub 2009 Jul 27. Bone Marrow Transplant. 2010. PMID: 19633692 Clinical Trial.

8

A randomized phase II study investigating the addition of the specific COX-2 inhibitor celecoxib to docetaxel plus carboplatin as first-line chemotherapy for stage IC to IV epithelial ovarian cancer, Fallopian tube or primary peritoneal carcinomas: the DoCaCel study.

Reyners AKL, de Munck L, Erdkamp FLG, Smit WM, Hoekman K, Lalisang RI, de Graaf H, Wymenga ANM, Polee M, Hollema H, van Vugt MATM, Schaapveld M, Willemse PHB; DoCaCel Study Group. Reyners AKL, et al. Among authors: lalisang ri. Ann Oncol. 2012 Nov;23(11):2896-2902. doi: 10.1093/annonc/mds107. Epub 2012 Jun 11. Ann Oncol. 2012. PMID: 22689176 Free article. Clinical Trial.

9

Efficacy and safety of durvalumab with olaparib in metastatic or recurrent endometrial cancer (phase II DOMEC trial).

Post CCB, Westermann AM, Boere IA, Witteveen PO, Ottevanger PB, Sonke GS, Lalisang RI, Putter H, Meershoek-Klein Kranenbarg E, Braak JPBM, Creutzberg CL, Bosse T, Kroep JR. Post CCB, et al. Among authors: lalisang ri. Gynecol Oncol. 2022 May;165(2):223-229. doi: 10.1016/j.ygyno.2022.02.025. Epub 2022 Mar 11. Gynecol Oncol. 2022. PMID: 35287967 Free article. Clinical Trial.

10

A multi-center prospective phase II study of high-dose chemotherapy in germ-cell cancer patients relapsing from complete remission.

Rodenhuis S, de Wit R, de Mulder PH, Keizer HJ, Sleijfer DT, Lalisang RI, Bakker PJ, Mandjes I, Kooi M, de Vries EG. Rodenhuis S, et al. Among authors: lalisang ri. Ann Oncol. 1999 Dec;10(12):1467-73. doi: 10.1023/a:1008328012040. Ann Oncol. 1999. PMID: 10643538 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters